Risks for EFS
| Risk group . | Training cohort (Harrell’s C statistic, 0.7134) . | Validation cohort (Harrell’s C statistic, 0.7236) . | ||||
|---|---|---|---|---|---|---|
| No. of events/No. of patients . | Hazard ratio (95% CI) . | P . | No. of events/No. of patients . | Hazard ratio (95% CI) . | P . | |
| Good (score, 0) | 33/490 | 1.00 | <.0001 | 8/159 | 1.00 | <.0001 |
| Intermediate (score, 1) | 31/293 | 1.64 (1.01-2.67) | .0482 | 12/98 | 2.52 (1.03-6.16) | .0431 |
| High (score, 2-3) | 104/287 | 6.73 (4.54-9.96) | <.0001 | 33/98 | 7.71 (3.56-16.71) | <.0001 |
| Risk group . | Training cohort (Harrell’s C statistic, 0.7134) . | Validation cohort (Harrell’s C statistic, 0.7236) . | ||||
|---|---|---|---|---|---|---|
| No. of events/No. of patients . | Hazard ratio (95% CI) . | P . | No. of events/No. of patients . | Hazard ratio (95% CI) . | P . | |
| Good (score, 0) | 33/490 | 1.00 | <.0001 | 8/159 | 1.00 | <.0001 |
| Intermediate (score, 1) | 31/293 | 1.64 (1.01-2.67) | .0482 | 12/98 | 2.52 (1.03-6.16) | .0431 |
| High (score, 2-3) | 104/287 | 6.73 (4.54-9.96) | <.0001 | 33/98 | 7.71 (3.56-16.71) | <.0001 |